Prof. Eli Keshet

Woll Brothers and Sisters Chair for Cardiovascular Research , Biochemistry & Molecular Biology, IMRIC

Share this
Why I became a researcher: 

I find intellectual excitement in exploring the basic mechanisms of biology and personal satisfaction in the productive clinical trials that result from the basic principles we uncover in our laboratory
At IMRIC, we are studying how blood vessels are formed. Since cancerous tumors depend on a blood supply in order to grow, the ability of scientists to control blood vessel formation would enable them to “starve tumors” as a method of cancer treatment.
This IMRIC research led us to VEG, a growth factor that can inhibit or promote the activity of tumor angiogenesis. This pioneering work has resulted in an FDA-approved antiangiogenic drug for treating colorectal cancer.


1975: Ph.D., the Hebrew University of Jerusalem

Selected Awards and Honors: 
2006: Emet Prize for excellence in Life Sciences
keshet [at] cc [dot] huji [dot] ac [dot] il
Researcher in the News

Congratulations To Our 6 researchers On Receiving The Prestigious European Research Council (ERC) 2012 Grant!

6 IMRIC Researchers Are Awarded 2012 Grants From The European Research Council: